Latest Articles
- Acknowledgment to ReviewersNeurology® Neuroimmunology & Neuroinflammation Acknowledgment to ReviewersJosep O. DalmauApril 27, 2022
- Research ArticleHeterogeneity of Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Patients With Myasthenia GravisAbeer H. Obaid, Chryssa Zografou, Douangsone D. Vadysirisack, et al.April 26, 2022
- Research ArticlePure Relapsing Short MyelitisPart of the Multiple Sclerosis Spectrum or New Entity?Zélia Poullet, Julie Pique, Adil Maarouf, et al.April 26, 2022
- Clinical/Scientific NoteRelapsing and Immune-Responsive Paroxysmal Jaw Clonus With Blepharospasm and Sialorrhea Associated With D2R AutoantibodiesYue Liu, Xiaoting Hao, Dong Zhou, et al.April 22, 2022
- EditorialProgrammed Cell Death Protein 1–Positive CD8+ T Cells in Multiple SclerosisExhausted Fighters or PeacekeepersJoost Smolders, Jörg HamannApril 22, 2022
- Clinical/Scientific NoteAutoimmune Encephalitis With mGluR1 Antibodies Presenting With Epilepsy, but Without Cerebellar SignsA Case ReportAnita M. Vinke, Shenghua Zong, Josien H. Janssen, et al.April 21, 2022
- Research ArticleEffects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple SclerosisA Mendelian Randomization StudyMarijne Vandebergh, Bénédicte Dubois, An GorisApril 07, 2022
- Research ArticleTranscription Factor c-Maf Promotes Immunoregulation of Programmed Cell Death 1–Expressed CD8+ T Cells in Multiple SclerosisShusuke Koto, Norio Chihara, Ritsu Akatani, et al.April 05, 2022
- ArticleIncreased Remyelination and Proregenerative Microglia Under Siponimod Therapy in Mechanistic ModelsMichael Dietrich, Christina Hecker, Elodie Martin, et al.March 30, 2022
Pages
Advertisement